NEW YORK, NY / ACCESS Newswire / August 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Tronox Holdings plc ("Tronox" or the "Company") (NYSE:TROX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Tronox and certain of its officers and/or directors […]
NEW YORK, NY / ACCESS Newswire / August 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE:AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether agilon and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ:CFLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Confluent and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / August 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of BellRing Brands, Inc. ("BellRing" or the "Company") (NYSE:BRBR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether BellRing and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / August 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Bumble Inc. ("Bumble" or the "Company") (NASDAQ:BMBL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Bumble and certain of its officers and/or directors have
NEW YORK, NY / ACCESS Newswire / August 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE:INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Inspire and certain of its officers and/or
New digital experience reflects NexusTek's commitment to solving the toughest technology challenges NexusTek, a leader in technology and managed services, today announced the launch of its redesigned website-a bold new digital experience that reflects the company's customer-obsessed, innovation-led approach to solving complex business challenges across the data, AI, cloud, and cybersecurity landscape. https://mma.prnewswire.com/media/2752551/nexustek_website_launch_press_release_v1_0.jpg The revamped
“I wanted to create an app system that would allow mentors to connect with and learn from professionals,” said the inventor, from New Castle,Del., “so I invented the ALHELENI. My design could cultivate a vibrant community by sharing a wealth of experience and expertise.” https://mma.prnewswire.com/media/2099578/InventHelp_Logo_jpg_Logo.jpg The invention provides a new social media personal growth platform.
The hydrogen detection market is expected to reach USD 0.50 billion by 2030 from USD 0.28 billion in 2025 at a CAGR of 11.8%, from 2025 to 2030 according to a new report by MarketsandMarkets™. Key drivers fueling the growth of the hydrogen detection market are the high adoption of fuel cells globally, increased use
(NASDAQ:UNCY), ATLANTA, Aug. 18, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC has filed a shareholder class action lawsuit against Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ:UNCY). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information, including allegations that: (i) Unicycive's readiness and ability to